VBCG
EXAS

Valley Brook Capital Group’s Exact Sciences EXAS Stock Holding History

Valley Brook Capital Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$13K – 200
2021
Q1 		$13K Hold
100
– – 0.01% 342
2020
Q4 		$13K Buy
+100
New +$12.1K 0.01% 308

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Valley Brook Capital Group's EXAS Position: Q2 2021 in Review

Valley Brook Capital Group sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 100 shares — an estimated $13K sold.

Valley Brook Capital Group first reported a position in EXAS in Q4 2020 and held it in 2 quarters. The position peaked at $13K in Q1 2021. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • Valley Brook Capital Group reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
  • Valley Brook Capital Group sold 100 Exact Sciences shares in Q2 2021, an estimated $13K.
  • Valley Brook Capital Group first reported a position in Exact Sciences in Q4 2020 and held it in 2 quarters.
  • Valley Brook Capital Group's Exact Sciences position peaked at $13K in Q1 2021.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on Valley Brook Capital Group's 13F filing for Q2 2021, filed 22 Jul 2021.